Expert Speaker Faculty Take a look at the esteemed speaker faculty for the 5th Viral Vector Process Development & Manufacturing Summit. Leading Biotech Experts Pharma Industry Leaders Pioneering Research Institutes Leading Biotech Experts Matthew Edwards Vice President Technical OperationsAffinia Therapeutics Jorge Santiago-Ortiz Vice President, CMC & Regulatory AffairsApertura Gene Therapy Aditya Dandekar DirectorCabaletta Bio Michael White CMC LeadCelosia Therapeutics Jing Li Associate Director, Viral Vector Analytical Tech TransferExelixis, Inc. Scott Jeffers Chief Technology OfficerGenSight Biologics Julia Rohlhill Associate Director - Viral Vector SciencesLegend Biotech Seth levy Vice President, ManufacturingModalis Therapeutics Wenbin Qi Associate DirectorNeurocrine Biosciences Jessie Sun Senior Director - Drug Substance, Manufacturing Science & TechnologyUltragenyx Pharmaceutical Inc. Jack Ren Global Director - Downstream Process Development & CMC DevelopmentUltragenyx Pharmaceutical Inc. Mukesh Mayani Senior Director, Global CMC DevelopmentUltragenyx Pharmaceutical Inc. Pranav Puri Associate Director, BioProcess DevelopmentVectorY Therapeutics Pharma Industry Leaders Brooke Hodge Upstream Process Development EngineerAstellas Pharma Andrew Tustian Executive Director, Preclinical Manufacturing & Process DevelopmentRegeneron Pharmaceuticals Zhe Zhang Associate DirectorRegeneron Pharmaceuticals Ying Liu Associate Director, Cell Culture & Process Development, Genomic Medicine UnitSanofi Pioneering Research Institutes Aziza Manceur Research OfficerNational Research Council Canada Explore the Agenda Discover proven strategies for increasing yields, reducing manufacturing costs, and building scalable viral vector platforms. View Presentations & Speakers Partner With Us Connect directly with the viral vector leaders seeking technologies, services, and partners to accelerate manufacturing success. Explore Sponsorship Options Join Viral Vector Leaders Benchmark approaches with senior CMC, process development, manufacturing, MSAT, and regulatory experts advancing viral vector-based therapies. Register Now